Fondaparinux: an effective bridging strategy in heparin-induced thrombocytopenia and mechanical circulatory support.
Alfred Hospital, Melbourne, Australia; Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Rochelle M
RM
Gellatly
Alfred Hospital, Melbourne, Australia.
Angeline
A
Leet
Alfred Hospital, Melbourne, Australia.
Kathryn E
KE
Brown
D000925:Anticoagulants / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000628:therapy*; D005500:Follow-Up Studies; D000077425:Fondaparinux; D016027:Heart Transplantation; D006353:Heart-Assist Devices / Q000009:adverse effects*; D006493:Heparin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011134:Polysaccharides / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced*; D013927:Thrombosis / Q000188:drug therapy / Q000517:prevention & control; D016896:Treatment Outcome
D000925:Anticoagulants; D011134:Polysaccharides; D006493:Heparin; D000077425:Fondaparinux